N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart Failure

Osaka General Medical Center160 enrolled

Overview

Our study is to investigate the effect of N-3 Fatty Acids for the prevention of atrial fibrillation in patients with acute heart failure or acute myocardial infarction

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Enrollment

160

Conditions

Acute Heart Failure Acute Myocardial Infarction

Interventions

Epadel, Eicosapentaenoic acidDRUG

Epadel 900mg, 2 times a day, during hospitalization

Eligibility

Sex: ALLMin age: 20 Years

Medical Language ↔ Plain English

Inclusion Criteria: * sinus rhythm patients with acute heart failure or acute myocardial infarction Exclusion Criteria: * pregnancy,allergy to epadel

Outcomes

Primary Outcomes

detection of atrial fibrillation on ECG monitoring

Time frame: anytime during hospitalization

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.